Back to IMVTView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Graves Disease
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
IMVT-1402Phase 3
Chronic Inflammatory Demyelinating Polyneuropathy
BatoclimabPhase 3
Thyroid Eye Disease
Batoclimab 680 mg SC weeklyPhase 3
Generalized Myasthenia Gravis
Batoclimab 680 milligrams (mg) subcutaneous (SC) weeklyPhase 2
Chronic Inflammatory Demyelinating Polyneuropathy
RVT-1401Phase 2
Myasthenia Gravis
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts